Tuğçe Aktaş is a Max Planck Research Group Leader at the Max Planck Institute for Molecular Genetics in Berlin, Germany. Her research focuses on the interactions between transposons and host genomes , particularly how these "selfish genetic elements" influence RNA processing networks and genomic stability. She leads the Quantitative RNA Biology lab, which investigates transposon suppression strategies and their evolutionary impact on transcriptomes.
Xin Li is an Associate Professor in the Department of Computer Science at the Whiting School of Engineering, Johns Hopkins University. He is a member of the theory group and conducts research in the theory of computation, with a focus on randomness in computation, complexity theory, coding theory, and cryptography. He has advised several Ph.D. students and is actively involved in organizing seminars and serving on program committees of major theoretical computer science conferences. Ph.D., University of Texas at Austin, 2011 B.S. and M.S., Tsinghua University, Beijing, China His research interests lie broadly in theoretical computer science, particularly in pseudorandomness , randomness extractors , and explicit combinatorial constructions . He has made significant contributions to the construction of two-source extractors and non-malleable codes. His earlier work includes research in quantum computing and human-computer interaction. The most recent publications show a strong trend in coding theory (especially insertion-deletion codes), extractors (two-source, affine, non-malleable), and streaming algorithms. His work combines deep combinatorial insights with applications in cryptography and complexity theory. Scientific Awards and Honors: Simons Postdoctoral Fellowship NSF CAREER Award CCF-1845349 Invited to Theory of Computing Special Issue (RANDOM 2018) Invited to SICOMP Special Issue (FOCS 2013) SICOMP Special Issue (FOCS 2011) Advising and Grants: Xin Li has advised multiple Ph.D. students including Kuan Cheng, Zhengzhong Jin, Yu Zheng, Songtao Mao, and Yan Zhong. He has served as a postdoctoral mentor and research assistant supervisor. He is supported by several grants including NSF Award CCF-1617713, NSF CAREER Award CCF-1845349, and the Johns Hopkins Catalyst Award. He co-organizes the theory seminar at CS@JHU and has served on the program committees of STOC, RANDOM, and other top conferences. Labs and Teams: Xin Li is a member of the theory group at the Johns Hopkins Department of Computer Science, which focuses on foundational aspects of computation, algorithms, and complexity.
Dr. Rajvinder Karda is an Associate Professor in Gene Therapy at the Institute for Women's Health, University College London (UCL). She holds a position in the Maternal & Fetal Medicine department and maintains her office at 86-96 Chenies Mews, London, WC1E 6HX. Her academic career at UCL has progressed steadily from Senior Research Fellow (2020-2022), to Lecturer (2022-2023), and currently Associate Professor (since October 2023). She also serves as Non-Clinical Lecturer in Gene Therapy at UCL. Dr. Karda completed her Doctor of Philosophy in Gene Transfer and Neuroscience at Imperial College London in 2016, following a Master of Research from University College London in 2011 and a BSc (Hons) from King's College London in 2010. Her research focuses primarily on developing pre-clinical gene therapy and RNA editing treatments for childhood epilepsy, with special emphasis on Dravet Syndrome. She also collaborates on pre-clinical gene therapy projects for rare childhood metabolic disorders, particularly those involving mitochondrial dysfunction. Analysis of Dr. Karda's recent publication record reveals a strong emphasis on AAV vector development and optimization for neurological conditions and metabolic disorders. Her work demonstrates particular expertise in treating Dravet Syndrome through multiple approaches including RNA editing, natural antisense transcript targeting, and NaV1.1 channel modulation. She has also made significant contributions to gene therapy for mitochondrial disorders affecting the liver, including Pyruvate Dehydrogenase Complex Deficiency and deoxyguanosine kinase deficiency. Board member of the British Gene and Cell Therapy Society Scientific Advisory Committee member for Dravet Foundation Charity (Spain) Scientific Advisory Committee member for Cure DHDDS Charity (UK) Dr. Karda has secured substantial research funding as Principal Investigator from MRC DPFS, LifeArc, GOSH Charity, Dravet Syndrome UK Charity, Cure DHDDS charity, and venture capital funds. As an educator, she co-leads modules on Basic Genetics and Technology and Fertility and Infertility: Science and Society at the Institute for Women's Health, and provides lectures on Molecular Aspects of Cell and Gene Therapy at the Institute for Child Health and Genetic Therapies for Neurological Diseases at the Institute of Neurology.
Prof. Dr. Yusuf Baran is the President of the Izmir Institute of Technology (İYTE) and Chairman of İzmir Technology Development Zone, with concurrent roles on the boards of Bilişim Vadisi AŞ and the Interuniversity Council (ÜAK). His academic career spans professorial positions at İYTE (2008–present) and Abdullah Gul University (2015–2018), focusing on molecular biology and genetics. His research explores cancer therapeutics , emphasizing leukemia drug resistance, nanomedicine-based drug delivery, and stem cell applications. Key interests include molecular mechanisms of flavonoids (e.g., apigenin, luteolin), miRNA regulation, HER2-targeted nanocarriers, and sphingolipid metabolism in cancer. His work bridges experimental hematology and translational innovation. Recent publications (2021–2024) highlight trends in overcoming chemoresistance through novel targets (STAT3, non-coding RNAs), advanced drug delivery systems (pH-sensitive micelles), and natural compounds. Articles frequently integrate molecular biology with nanotechnology and metabolism studies. Awards & Leadership: Beni Solow Award (2017) Executive roles: Global Young Academy, TWAS, Turkish Academy of Sciences Founding member: Biodiversity to Biomedicine Consortium He leads institutional R&D initiatives and national science policy committees, with no current students or part-time affiliations noted.
Andrea Schorn is an Assistant Professor at Cold Spring Harbor Laboratory (CSHL), where she leads the Schorn Laboratory and is a member of the Cancer Center and the School of Biological Sciences. Her research centers on transposable elements and the role of small RNAs—particularly tRNA fragments—in genome regulation and defense. Ph.D., Biochemistry, Max-Delbrück Center for Molecular Medicine, Freie Universität Berlin (2004–2009) Postdoctoral Fellow, Cold Spring Harbor Laboratory (2009–2019) Research Assistant Professor, CSHL (2019–2021) Assistant Professor, CSHL (2021–present) Her research focuses on how transposable elements—remnants of ancient retroviruses—interact with host genomes. She investigates how tRNA-derived small RNAs silence these elements during early development and in diseases like cancer. Her lab discovered that a conserved 18-nucleotide motif in retroelements is targeted by tRNA fragments, revealing a key mechanism in genome stability and epigenetic regulation. This work connects to broader themes in gene regulation, evolutionary biology, and antiviral defense. Her recent publications span high-impact journals such as Cell , Nature Structural & Molecular Biology , and Nature Communications , with a consistent focus on small RNAs, epigenetics, and transposon control. Her work shows a strong trend toward understanding RNA modifications, intergenerational inheritance, and the dual roles of transposable elements as both threats and essential genomic components. Fellowship of the International PhD Program of the Helmholtz Graduate School (2004–2007) Associate Faculty Member, Faculty of 1000 (2010–2016) Schorn mentors numerous graduate and undergraduate students and has served on examination committees. Her lab actively participates in national and international conferences, delivering invited talks on epigenetics and transposable elements. She is involved in the Gene Regulation and Inheritance program at CSHL and collaborates extensively within the institution and beyond. Her lab develops transposition assays to visualize and quantify transposon activity, contributing to both basic science and potential therapeutic applications in cancer and reproductive health.
Kristin Eckert is a Professor at Penn State University, affiliated with the Department of Pathology and Laboratory Medicine and Department of Molecular and Precision Medicine . Her research focuses on DNA replication, genome instability, and their roles in carcinogenesis through the study of specialized DNA structures like G-quadruplexes and microsatellites. Her work examines how DNA polymerases interact with non-B DNA structures (e.g., G-quadruplexes, AT/TA repeats) and their implications for genomic stability and cancer development . Recent studies highlight the interplay between oncogenic signaling , DNA repair mechanisms , and replication errors in disease contexts. Kristin's research has led to numerous publications in Genomics , Biochemistry , and Cancer Biology . These articles investigate the functional significance of DNA structures , polymerase specificity , and mechanisms of mutation across the human genome. She is a member of the Mechanisms of Carcinogenesis program at the Penn State Cancer Institute and contributes to collaborative projects in precision medicine and DNA damage response .
Professor Rukset Attar is a distinguished academic researcher and clinician at Yeditepe University Faculty of Medicine, Department of Obstetrics and Gynecology. She has held progressively senior academic positions at the university since 2007, advancing from Assistant Professor to Associate Professor in 2012, and ultimately achieving the rank of Professor in 2017. Her academic journey began with medical training at Istanbul University Faculty of Medicine (1986-1992), followed by specialization in obstetrics and gynecology (1992-1997), and culminated in a PhD in Molecular Medicine from Istanbul University (1998-2004). Her research interests span multiple interconnected domains within molecular medicine and gynecological oncology. Professor Attar has made significant contributions to understanding cancer biology, particularly focusing on metastasis mechanisms, signaling pathways in gynecological cancers, and the role of natural products in cancer prevention and treatment. Her work frequently examines genetic polymorphisms in Turkish populations related to gynecological conditions, including ovarian cancer and uterine leiomyomas. She has pioneered research on how natural compounds regulate oncogenic signaling pathways, with particular emphasis on TRAIL, Wnt/β-catenin, JAK/STAT, TGF/SMAD, and other critical pathways. Professor Attar's extensive publication record demonstrates a clear research trajectory from clinical gynecology toward molecular oncology. Her recent publications (2023-2025) reveal a sophisticated integration of traditional gynecological expertise with cutting-edge molecular techniques, particularly in the areas of non-coding RNA biology, microbiome-endocrine interactions, and novel cell death mechanisms in cancer. She has expanded her research to include polycystic ovary syndrome, chronic pelvic pain, and innovative approaches to cancer chemoprevention using natural compounds. Her scholarly impact is evident through numerous peer-reviewed publications in high-impact journals, particularly in Cellular and Molecular Biology, Gene, and various oncology-focused publications. Professor Attar has also made substantial contributions to the scientific literature through book chapters and edited volumes, particularly in the areas of cancer metastasis and molecular medicine. Professor Attar maintains an active research program that bridges clinical gynecology with molecular oncology, demonstrating exceptional productivity with continuous publication output spanning over two decades. Her work represents a sophisticated integration of clinical practice with advanced molecular research methodologies, positioning her as a leading researcher in the molecular aspects of gynecological diseases.
Michael Montgomery is a Lecturer at the Anderson School of Business at UCLA, focusing on media-technology convergence and executive strategy. His career spans finance, media, and technology sectors, with expertise in M&A, equity financing, and corporate restructuring. Co-Founder & President of Montgomery & Co., LLC (1999-2013) Former CEO of Sega GameWorks and Senior Executive at DreamWorks SKG Leadership roles at Walt Disney Company and Arco Solar Board Director at DreamWorks Animation, Synacor, Open Methods, and M3Bio Education : MBA, Amos Tuck School at Dartmouth College (1977) BA (magna cum laude), Rufus Choate Scholar Research Focus : While his academic role emphasizes business strategy, recent Google Scholar publications indicate interdisciplinary engagement with: Genomic analysis of rare variants and structural variation Transcriptomic profiling in aging and disease Exercise physiology and multi-omic adaptation Advanced DNA/RNA sequencing technologies and diagnostics Scientific Awards : No explicit awards mentioned in the text. Advising & Boards : Served as board member/director for multiple public and private companies, with leadership roles in audit committees and strategic initiatives.
Archana Singh is a Research Fellow at the Department of Plant Sciences , University of Cambridge. Her work bridges plant biology, molecular pathology, and interdisciplinary research, including cancer biology. Affiliated with the Gene Expression research group, she investigates plant-microbe interactions, RNA processing, and genomic mechanisms. Research highlights include Plant immunity modulation by aphid and phytoplasma effectors RNA biology in viral resistance and gene silencing Metastasis mechanisms in paediatric bone cancers Comparative genomics of plant pests (e.g., woolly apple aphid) Non-coding RNA dynamics in development and disease Her publications span plant virology, molecular oncology, and computational biology, reflecting a cross-disciplinary approach. Contact: as3130@cam.ac.uk .
Professor Miguel Constancia is a leading researcher at the University of Cambridge's School of Clinical Medicine, holding dual appointments in the Department of Obstetrics & Gynaecology and the Metabolic Research Laboratories (MRL). His work bridges reproductive biology, epigenetics, and metabolic physiology with significant contributions to understanding genomic imprinting and fetal programming. His research focuses on genetic and epigenetic control of growth and metabolism , particularly examining how imprinted genes like IGF2 regulate placental development, fetal growth, and long-term metabolic health. Current investigations explore epigenetic mechanisms linking environmental exposures to adult disease programming, with emphasis on obesity-related metabolic disorders and transgenerational inheritance patterns. Analysis of his recent publications reveals consistent investigation of IGF2 signaling pathways across multiple biological contexts - from placental endocrine function to neuronal memory formation. His work demonstrates how imprinted genes serve as critical mediators between maternal environment and fetal developmental trajectories, with significant implications for understanding metabolic syndrome, growth restriction, and reproductive disorders. Professor Constancia actively contributes to interdisciplinary reproductive research through Cambridge Reproduction, where he participates in initiatives including the Cambridge Lactation Network and Remaking Reproduction projects. His research methodology integrates mouse genetic models with human epigenetic studies to elucidate conserved mechanisms of developmental programming.
Associate Professor Torsten Krude is a leading researcher in the Department of Zoology at the University of Cambridge , focusing on the regulation of chromosomal DNA replication in eukaryotic cells. He also serves as Vice-President of the Darwin College Boat Club, indicating his engagement beyond research. His work primarily investigates how small non-coding RNAs (e.g., Y RNAs, stem-bulge RNAs) regulate DNA replication initiation. Key research themes include: Identifying replication proteins that interact with Y RNAs Characterizing functional domains of Y RNAs Elucidating Y RNA-chromatin interactions Mapping human DNA replication origins Exploring evolutionary conservation of Y RNA homologues The 15 most recent publications highlight his expertise in DNA replication mechanisms, with a focus on Y RNAs, chromatin dynamics, and epigenetic regulation of replication origins. His lab has developed cell-free systems to study replication initiation and advanced methodologies like ini-seq for genome-wide origin mapping.
Dr Johnson Jianzhong Liu is a researcher at the University of New South Wales , affiliated with the School of Medical Sciences and Department of Pharmacology . His work bridges cancer pharmacology, experimental therapeutics, and drug transporter biology. BSc, MSc in Veterinary Medicine from Northwest A & F University PhD in Pharmacology from South China Agricultural University Graduate Certificate in University Learning & Teaching (GCULT), UNSW Dr Liu’s research focuses on copper transporters and organic cation transporters in chemotherapy-induced neurotoxicity, Wnt signaling in targeted cancer therapy, and genetic polymorphisms affecting platinum drug response and lung cancer risk in Chinese Han populations. His lab employs in vitro and in vivo models to study vascular-disrupting flavonoids and mulberry fruit extracts in cancer treatment. Recent publications highlight his expertise in platinum-based drug mechanisms ( oxaliplatin resistance via MRP2), cancer-related miRNA regulation , and traditional Chinese medicine applications for inflammation and tumor suppression. His work spans pharmacokinetics , drug transport , and pharmacogenomics . Dr Liu serves on the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists and the American Association for Cancer Research. He mentors PhD, Masters, Honours, and ILP students in projects involving Wnt signaling and drug transporter modulation.
Stephen Krawetz is the Charlotte B. Failing Professor at Wayne State University School of Medicine , affiliated with the Department of Obstetrics and Gynecology and the Center for Molecular Medicine and Genetics . As a Professor , he has taught courses such as Reproductive Sciences Program and Stem Cell Biology , while leading the Krawetz Lab. His research focuses on sperm RNAs , epigenetics , systems biology , and 4D genome dynamics. Key projects include analyzing paternal RNA contributions to fertilization, chromatin-mediated differentiation, and genome reprogramming for therapeutic applications. Recent work explores systems biology trends (e.g., Letrozole vs Clomiphene trials), epigenetic aging in sperm, and RNA element stability in reproductive health. His scientific advisory roles span PhD committees and international collaborations. Email: steve@compbio.med.wayne.edu
Daniel Colin Turner is a post-doctoral research fellow at the Norwegian School of Sport Sciences (NIH) , based in the Department of Physical Performance . He lectures in cell biology and molecular physiology within the bachelor's and master's programmes. Education B.Sc in Sport and Exercise Science, Liverpool John Moores University, UK M.Sc in Sports Nutrition, Liverpool John Moores University, UK Ph.D in Molecular Exercise Physiology / Bioengineering, Liverpool John Moores University and Keele University, UK Research Interests Turner's research centres on skeletal muscle biology with a strong emphasis on genetics and epigenetics . He explores how epigenetic mechanisms mediate muscle memory following exercise and disuse, employing bioengineering approaches and in vitro models. Additional interests include molecular exercise physiology and sports nutrition , integrating multi-omics techniques to understand muscle adaptation. Publications and Impact Since 2021, Turner has co-authored numerous high-impact papers investigating epigenetic memory in human skeletal muscle, the methylome response to dietary interventions, and the molecular underpinnings of muscle anabolism. His work appears in leading journals such as the American Journal of Physiology and The FASEB Journal . Scientific Awards No specific awards or fellowships have been listed in the provided text. Teaching and Supervision Turner teaches cell biology and molecular physiology to undergraduate and graduate students. No explicit list of supervised students is provided. Laboratories and Collaboration He collaborates extensively with international researchers, including teams from Liverpool John Moores University, Keele University, and other European institutions, leveraging cutting-edge molecular techniques and in vitro exercise models.
Lawrence I. Grossman, PhD is the Henry L. Brasza Professor of Molecular Medicine and Genetics and Director of the Center for Molecular Medicine and Genetics at Wayne State University School of Medicine, where he also holds a professorship in Internal Medicine. His laboratory is located in Scott Hall and focuses on mitochondrial molecular genetics, with particular emphasis on cytochrome c oxidase (COX) regulation and mitochondrial disease mechanisms. Grossman earned his PhD from Albert Einstein College of Medicine in 1971, establishing a long and distinguished career in mitochondrial research. His educational foundation has supported decades of pioneering work in mitochondrial genetics and function. Dr. Grossman's research centers on mitochondrial molecular genetics, with particular focus on cytochrome c oxidase (COX) and its regulators. His lab investigates how mitochondria, as semi-autonomous organelles with their own DNA, cooperate with the nucleus to maintain cellular energy production. A major focus is on mitochondrial disease mechanisms, including genomic approaches to understanding population disease susceptibilities. The lab also studies the evolutionary emergence of the enlarged neocortex, the brain's most highly oxygen-utilizing tissue. Recent work has increasingly emphasized MNRR1/CHCHD2, a bi-organellar protein that regulates metabolism in mitochondria and functions as a transcription factor in the nucleus, with implications for cancer, pregnancy complications, and metabolic disorders. Analysis of Dr. Grossman's recent publications (2021-2024) reveals a strong translational focus, with significant work connecting mitochondrial function to clinical conditions including preterm birth, preeclampsia, ovarian cancer, and viral infections. His research demonstrates a clear trajectory from basic mitochondrial mechanisms toward understanding their role in human disease pathophysiology, with particular emphasis on the dual-function protein MNRR1/CHCHD2. Dr. Grossman actively mentors graduate students, currently accepting new M.S. students for 2025-2026 while not accepting new Ph.D. students during that period. His laboratory has produced numerous publications with collaborators across multiple disciplines, demonstrating strong interdisciplinary connections. The Grossman Laboratory operates as part of the Center for Molecular Medicine and Genetics, which functions as a campus-wide unit responsible to both the Dean of the School of Medicine and the Vice President for Research at Wayne State University. The lab employs biochemical, molecular biological, and computational approaches to investigate mitochondrial energy regulation, with particular emphasis on cytochrome c oxidase isoforms and their tissue-specific regulation.
